美国的静脉通路装置市场:各产品类型，各用途，各终端用户，各地区，机会，预测，2018年～2032年

美国血管通路设备市场规模预计将从 2024 年的 18.2275 亿美元增长到 2032 年的 28.2064 亿美元，在 2025-2032 年预测期内的复合年增长率为 5.59%。癌症、肾衰竭和糖尿病等慢性疾病的盛行率不断上升，需要频繁地进行血管介入治疗。包括抗感染和压力监测导管的开发在内的技术进步显着提高了患者的安全性和手术效率。此外，对门诊护理的日益增长的偏好和门诊手术中心的扩张正在推动对先进血管通路解决方案的需求。

例如，碧迪公司（BD）于2024年10月推出了BD EZI-O腹腔内血管通路系统。此尖端工具可为重症监护患者在紧急情况下提供快速的血管通路。该技术旨在满足紧急医疗需求，可透过骨髓快速有效地输送液体和药物。这项创新的目的是提高护理质量，特别是在休克、心臟骤停和创伤等棘手情况下的护理品质。

美国住院率与慢性病负担上升

在美国，癌症、心血管疾病、糖尿病和慢性肾臟病等慢性疾病的流行是血管通路设备需求的主要驱动力。随着人口老化和生活方式相关疾病的总体增加，需要长期静脉治疗、透析和化疗的患者数量正在稳步增加。这些治疗通常需要频繁或持续地进入血液，因此血管通路装置至关重要。此外，因外科手术和重症监护而住院和门诊就诊的人数激增，推动了对可靠、高效的血管通路解决方案的需求。随着美国医疗保健系统不断转向提高病患安全性和减少导管相关併发症，具有增强生物相容性和感染预防功能的先进血管通路设备的使用也在增加。这证实了医疗保健对血管通路的广泛需求及其在患者管理中的核心作用。例如，2024年2月，美国疾病管制与预防中心发布的数据显示，大约每10个美国成年人中就有6人患有至少一种慢性病，每10人中就有4人患有两种或两种以上的慢性病，​​促使住院治疗和长期照护的需求显着增加。

本报告提供美国的静脉通路装置市场相关调查，提供市场概要，以及各产品类型，各用途，各终端用户，各地区趋势，及加入此市场的主要企业简介等资讯。

目录

第1章 计划的范围和定义

第2章 调查手法

第3章 美国的关税的影响

第4章 摘要整理

第5章 美国的静脉通路装置市场预测，2018年～2032年

• 市场规模分析与预测
• 市场占有率分析与预测
  • 各产品类型
    • 中心静脉通路装置
    • 末梢静脉通路装置
    • 配件
  • 各用途
    • 医药品管理局
    • 水分和营养的给药
    • 输血
    • 诊断
  • 各终端用户
    • 医院
    • 诊所
    • 门诊病人手术中心
    • 其他
  • 各地区
    • 东北部
    • 中西部
    • 西部
    • 南部
  • 各企业市场占有率分析(前五名公司以及其他- 各金额，2024年)
• 2024年的市场地图分析

第6章 价值链分析

第7章 需求供给分析

第8章 进出口的分析

第9章 波特的五力分析

第10章 大环境分析

第11章 价格分析

第12章 市场动态

• 市场促进因素
• 市场课题

第13章 市场趋势与发展

第14章 法规结构和革新

第15章 竞争情形

• 前五名市场领导的竞争矩阵
• 前五名参与企业的SWOT分析
• 前10名市场主要企业的形势
  • Becton Dickinson and Company
  • Teleflex Incorporated
  • Nipro Medical Corporation
  • ICU Medical, Inc.
  • AngioDynamics, Inc.
  • Medtronic plc
  • Braun Holding GMBH & Co. KG
  • Terumo Corporation
  • Cook Medical Inc.
  • Access Vascular Inc.

第16章 策略性建议

第17章 关于调查公司·免责声明

United States vascular access devices market is projected to witness a CAGR of 5.59% during the forecast period 2025-2032, growing from USD 1,822.75 million in 2024 to USD 2,820.64 million in 2032. The rising prevalence of chronic conditions such as cancer, renal failure, and diabetes requires frequent vascular interventions. Technological advancements, including developing anti-infective and pressure-monitoring catheters, significantly improve patient safety and procedural efficiency. Moreover, the growing preference for outpatient care and the expansion of ambulatory surgical centers are fueling the demand for advanced vascular access solutions.

For instance, Becton, Dickinson and Company (BD) launched the BD EZI-O Intraosseous Vascular Access System in October 2024. This cutting-edge tool offers critical care patients' quick vascular access in emergencies. The technique, which was created to meet urgent medical needs, allows quick and effective delivery of fluids and medications through bone marrow. The goal of the innovation is to improve the quality of care, especially in difficult situations like shock, cardiac arrest, or trauma.

Rising Hospitalization Rates and Increasing Chronic Disease Burden in the U.S.

The growing prevalence of chronic diseases such as cancer, cardiovascular disorders, diabetes, and chronic kidney disease is significantly driving the demand for vascular access devices in the United States. With the aging population and an overall increase in lifestyle-related illnesses, the number of patients requiring long-term intravenous treatments, dialysis, or chemotherapy is rising steadily. These treatments typically involve frequent or continuous access to the bloodstream, making vascular access devices essential. Furthermore, the surge in hospital admissions and outpatient visits for surgical procedures and critical care support enhances the demand for reliable and efficient vascular access solutions. As the U.S. healthcare system continues to shift toward improving patient safety and reducing catheter-related complications, the usage of advanced vascular access devices with enhanced biocompatibility and infection-prevention features is also increasing. This driver underscores the broader healthcare need for vascular access and its central role in patient management. For example, in February 2024, the CDC published data showing that about 6 in 10 adults in the United States have at least one chronic disease, and 4 in 10 have two or more, significantly increasing hospital admissions and long-term care needs.

Technological Advancements in Vascular Access Devices Improve Patient Safety and Outcomes

Continuous innovation in vascular access technologies has been a significant growth factor in the United States market. Manufacturers focus on developing catheters and associated components that minimize the risk of bloodstream infections, thrombosis, and mechanical failures. Advanced coatings such as antimicrobial and antithrombogenic layers, integrated stabilization features, and closed catheter systems are widely used to enhance safety and reduce hospital-acquired infections. In addition, the integration of imaging-guided placement techniques such as ultrasound and real-time catheter tip positioning systems has improved the precision of device insertion and reduced complications. These technologies enhance patient safety and comfort and enable care providers to reduce the overall cost of complications and reductions. The growing demand for devices that support long-term access with minimal interventions is leading hospitals and clinics across the United States. to increasingly adopt next-generation vascular access devices, thereby contributing to overall market growth. Moreover, in July 2023, Access Vascular Inc. announced positive clinical results from its HydroPICC catheter, a peripheral vascular access device that significantly reduced complications like thrombosis and occlusion in a real-world clinical setting.

Peripheral Vascular Access Devices Hold a Significant Market Share

Peripheral vascular access devices represent a significant segment of the United States vascular access devices market, primarily due to their widespread use across multiple clinical applications. These devices are commonly used in inpatient and outpatient settings for short-term therapies such as hydration, medication delivery, and diagnostic testing. Their minimally invasive nature, ease of insertion, and lower complication rates make them a preferred option for emergency care, pediatric treatments, and routine hospital procedures. Midline catheters and peripheral intravenous (PIV) lines have seen increased adoption due to their suitability for intermediate-duration therapies, reducing the need for more invasive central lines. With an increasing number of ambulatory surgeries and a rise in emergency department visits across the United States, peripheral vascular access solutions are in high demand. Their versatility, cost-effectiveness, and growing technological improvements-such as self-sealing valves and securement systems-further accelerate the segment's growth trajectory. In May 2023, Teleflex Incorporated launched the Arrow VPS Rhythm DLX Device, a vascular positioning system with electrocardiogram-based tip confirmation technology, aimed at enhancing precision and patient safety during catheter placements.

Future Market Scenario (2025-2032F)

The United States vascular access devices market is expected to witness robust growth due to rising hospital admissions, the increasing burden of chronic diseases, and technological innovations in catheter materials and placement systems. Growing demand for minimally invasive procedures and enhanced infection prevention measures will also support market expansion. Additionally, supportive reimbursement frameworks and ongoing clinical innovations are likely to create new opportunities across hospitals and ambulatory surgical centers. BD (Becton, Dickinson and Company) introduced the PIVO Pro, a ground-breaking needleless blood collection tool, in November 2023. Upon FDA approval, the device became the first to function smoothly with both integrated and long-term peripheral IV catheters, including the Nexiva system, which now features NearPort IV Access.

Key Players Landscape and Outlook

The key players in the market are significantly investing in the development of vascular access devices and are utilizing strategies such as mergers, acquisitions, partnerships, and new product launches to improve their services and competitiveness. Such efforts will propel significant growth in the market, allowing large-cap industry players to increase their presence and, therefore, find new opportunities in this market.

Mozarc Medical, a joint venture between Medtronic (India Medtronic Private Limited) and DaVita Inc., aimed at promoting advancements in kidney treatment, was established in April 2023. Mozarc wants to improve accessibility and flexibility for people with chronic renal disease by creating home-based and portable dialysis systems. The program demonstrates both businesses' dedication to using technology and patient-centered care to revolutionize kidney health management.

Table of Contents

1. Project Scope and Definitions

2. Research Methodology

3. Impact of U.S. Tariffs

4. Executive Summary

5. United States Vascular Access Devices Market Outlook, 2018-2032F

• 5.1. Market Size Analysis & Forecast
  • 5.1.1. By Value
  • 5.1.2. By Volume
• 5.2. Market Share Analysis & Forecast
  • 5.2.1. By Product Type
    • 5.2.1.1. Central Vascular Access Device
    • 5.2.1.2. Peripheral Vascular Access Device
    • 5.2.1.3. Accessories
  • 5.2.2. By Application
    • 5.2.2.1. Drug Administration
    • 5.2.2.2. Fluid and Nutrition Administration
    • 5.2.2.3. Blood Transfusion
    • 5.2.2.4. Diagnostics
  • 5.2.3. By End-user
    • 5.2.3.1. Hospitals
    • 5.2.3.2. Clinics
    • 5.2.3.3. Ambulatory Surgical Centers
    • 5.2.3.4. Others
  • 5.2.4. By Region
    • 5.2.4.1. Northeast
    • 5.2.4.2. Midwest
    • 5.2.4.3. West
    • 5.2.4.4. South
  • 5.2.5. By Company Market Share Analysis (Top 5 Companies and Others - By Value, 2024)
• 5.3. Market Map Analysis, 2024
  • 5.3.1. By Product Type
  • 5.3.2. By Application
  • 5.3.3. By End-user
  • 5.3.4. By Region

6. Value Chain Analysis

7. Demand Supply Analysis

8. Import and Export Analysis

9. Porter's Five Forces Analysis

10. PESTLE Analysis

11. Pricing Analysis

12. Market Dynamics

• 12.1. Market Drivers
• 12.2. Market Challenges

13. Market Trends and Developments

14. Regulatory Framework and Innovation

15. Competitive Landscape

• 15.1. Competition Matrix of Top 5 Market Leaders
• 15.2. SWOT Analysis for Top 5 Players
• 15.3. Key Players Landscape for Top 10 Market Players
  • 15.3.1. Becton, Dickinson and Company
    • 15.3.1.1. Company Details
    • 15.3.1.2. Key Management Personnel
    • 15.3.1.3. Products and Services
    • 15.3.1.4. Financials (As Reported)
    • 15.3.1.5. Key Market Focus and Geographical Presence
    • 15.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisition
  • 15.3.2. Teleflex Incorporated
  • 15.3.3. Nipro Medical Corporation
  • 15.3.4. ICU Medical, Inc.
  • 15.3.5. AngioDynamics, Inc.
  • 15.3.6. Medtronic plc
  • 15.3.7. Braun Holding GMBH & Co. KG
  • 15.3.8. Terumo Corporation
  • 15.3.9. Cook Medical Inc.
  • 15.3.10. Access Vascular Inc.

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

16. Strategic Recommendations

17. About Us and Disclaimer

List of Tables

• Table 1. Competition Matrix of Top 5 Market Leaders
• Table 2. Mergers & Acquisitions/ Joint Ventures (If Applicable)
• Table 3. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

• Figure 1. United States Vascular Access Devices Market, By Value, In USD Million, 2018-2032F
• Figure 2. United States Vascular Access Devices Market, By Volume, In Units, 2018-2032F
• Figure 3. United States Vascular Access Devices Market Share (%), By Product Type, 2018-2032F
• Figure 4. United States Vascular Access Devices Market Share (%), By Application, 2018-2032F
• Figure 5. United States Vascular Access Devices Market Share (%), By End-user, 2018-2032F
• Figure 6. United States Vascular Access Devices Market Share (%), By Region, 2018-2032F
• Figure 7. By Product Type Map-Market Size (USD Million) & Growth Rate (%), 2024
• Figure 8. By Application Map-Market Size (USD Million) & Growth Rate (%), 2024
• Figure 9. By End-user Map-Market Size (USD Million) & Growth Rate (%), 2024
• Figure 10. By Region Map-Market Size (USD Million) & Growth Rate (%), 2024